Free Account Opening + AMC Free Demat
Loading...

Mankind Pharma IPO vs Tata Technologies IPO

Comparision between Mankind Pharma IPO and Tata Technologies IPO.

IPO Details

Mankind Pharma IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Tata Technologies IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Mankind Pharma IPO is up to ₹4,326.36 Cr whereas the issue size of the Tata Technologies IPO is up to ₹3,042.51 Cr. The final issue price of Mankind Pharma IPO is ₹1,080.00 per share and of Tata Technologies IPO is ₹500.00 per share.

  Mankind Pharma IPO Tata Technologies IPO
Face Value ₹1 per share ₹2 per share
Issue Price (Lower) ₹1,026.00 per share ₹475.00 per share
Issue Price (Upper) ₹1,080.00 per share ₹500.00 per share
Issue Price (Final) ₹1,080.00 per share ₹500.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 13 shares 30 shares
Fresh Issue Size
Fresh Issue Size (Amount)
OFS Issue Size 4,00,58,844 shares 6,08,50,278 shares
OFS Issue Size (Amount) up to ₹4,326.36 Cr up to ₹3,042.51 Cr
Issue Size Total 4,00,58,844 shares 6,08,50,278 shares
Issue Size Total (Amount) up to ₹4,326.36 Cr up to ₹3,042.51 Cr

IPO Timetable

Mankind Pharma IPO opens on Apr 25, 2023, while Tata Technologies IPO opens on Nov 22, 2023. The closing date of Mankind Pharma IPO and Tata Technologies IPO is Apr 27, 2023, and Nov 24, 2023, respectively.

  Mankind Pharma IPO Tata Technologies IPO
Anchor Bid Date Apr 24, 2023 Nov 21, 2023
Issue Open Apr 25, 2023 Nov 22, 2023
Issue Close Apr 27, 2023 Nov 24, 2023
Basis Of Allotment (Tentative) May 03, 2023 Nov 28, 2023
Initiation of Refunds (Tentative) May 04, 2023 Nov 29, 2023
Credit of Share (Tentative) May 05, 2023 Nov 29, 2023
Listing date (Tentative) May 09, 2023 Nov 30, 2023
Anchor Lockin End date 1 Jun 02, 2023 Dec 28, 2023
Anchor Lockin End date 2 Aug 01, 2023 Feb 26, 2024

Financials

Mankind Pharma IPO P/E ratio is 32.5, as compared to Tata Technologies IPO P/E ratio of 32.53.

  Mankind Pharma IPO Tata Technologies IPO
Financial
Mankind Pharma Limited Financial Information (Restated Consolidated)
Period EndedTotal AssetsTotal RevenueProfit After TaxNet WorthReserves and SurplusTotal Borrowing
31-Mar-205,073.295,975.651,056.153,485.313,436.34126.92
31-Mar-216,372.636,385.381,293.034,722.004,674.39234.53
31-Dec-218,043.886,218.291,260.245,965.465,916.86268.70
31-Mar-229,147.747,977.581,452.966,155.236,106.06868.03
31-Dec-229,273.756,777.821,015.987,145.897,094.12167.93
Amount in ₹ Crore

Tata Technologies Limited Financial Information (Restated Consolidated)

Tata Technologies Limited's revenue increased by 25.81% and profit after tax (PAT) rose by 42.8% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended30 Sep 202331 Mar 202331 Mar 202231 Mar 2021
Assets5,142.425,201.494,218.003,572.74
Revenue2,587.424,501.933,578.382,425.74
Profit After Tax351.90624.04436.99239.17
Net Worth2,853.132,989.472,280.162,142.15
Reserves and Surplus2,455.292,605.602,028.931,897.46
Total Borrowing
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue) 79.00% 66.79%
Promoter Shareholding (Post-Issue) 76.50% 55.39%
P/E Ratio 32.5 32.53
Market Cap ₹43263.60 Cr. ₹20283.43 Cr.
ROE 27.60%%
ROCE 26.10%%
Debt/Equity
EPS ₹33.20 ₹15.37
RoNW 27.70%% 20.87%%

Shares Offered

In the Mankind Pharma IPO retail investors (RII) are offered 1,40,20,596 shares while in Tata Technologies IPO retail investors are offered 1,40,20,596 shares. Qualified institutional buyers (QIB) are offered 80,11,769 shares in Mankind Pharma IPO and 1,05,47,382 shares in Tata Technologies IPO.

  Mankind Pharma IPO Tata Technologies IPO
Anchor Investor Reserveration 1,20,17,652 shares 1,58,21,071 shares
Market Maker Reserveration
QIB 80,11,769 shares 1,05,47,382 shares
NII 60,08,827 shares 79,10,537 shares
RII 1,40,20,596 shares 1,84,57,919 shares
Employee 0 shares 20,28,342 shares
Others
Total 2,80,41,192 shares 4,50,29,207 shares

Bids Received (Subscription)

Mankind Pharma IPO subscribed 15.32x in total, whereas Tata Technologies IPO subscribed 69.43x.

  Mankind Pharma IPO Tata Technologies IPO
QIB (times) 49.16x 203.41x
NII (times) 3.80x 62.11x
Big NII (times) 4.99x 70.67x
Small NII (times) 1.41x 44.98x
RII (times) 0.92x 16.50x
Employee (times) 3.70x
Other (times) 29.20x
Total (times) 15.32x 69.43x

Comments

Add a public comment...